The AHA Sept. 9 released a report highlighting how hospitals’ arrangements with community and specialty pharmacies improve access to care for underserved patients.

“The accessibility of community pharmacies presents a convenient, familiar, and dependable source of care,” the report notes. “This is especially true for those living in rural communities or who lack easy access to transportation.”

The report includes a number of data points on how 340B community and specialty pharmacies are located in counties that are experiencing issues that affect individuals’ health, including lack of insurance, food insecurity, high unemployment and severe housing problems.

“Importantly, these arrangements allow hospitals to better fulfill their 340B mission — to stretch scarce resources and expand access to care for more patients,” the report notes. “Collectively these data demonstrate the need for Congress to continue its strong bipartisan support of the program and reject efforts by big drug companies to undermine the program and the innumerable benefits it affords patients across the country.”
 

Related News Articles

Headline
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services…
Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get…
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state’s 340B contract pharmacy law…
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…